Literature DB >> 1677606

Hippocampal mu-receptors mediate opioid reinforcement in the CA3 region.

K E Stevens1, G Shiotsu, L Stein.   

Abstract

Dependence on reinforcing chemicals is manifested when drug-seeking and drug-taking behaviors come to dominate the response repertoire. Clinical observations suggest that the craving and compulsive drug-seeking that characterize drug dependence are aroused by memories of the reinforcing drug experience. If so, a brain structure intimately associated with memory--the hippocampus--would be a plausible substrate for drug reinforcement effects. We report here that drug-naive rats rapidly learn to self-administer the opioid peptide dynorphin A in the CA3 region of hippocampus, and that this behavior is blocked by co-administration of the non-selective opiate antagonist naloxone. Subsequent studies demonstrated that coadministration of mu-, but not kappa- or delta-opioid antagonists also blocked self-administration behavior. We conclude that mu-receptors in the CA3 region of hippocampus may be important target sites for opioid dependence.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677606     DOI: 10.1016/0006-8993(91)91263-z

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Expression of a heroin contextually conditioned immune effect in male rats requires CaMKIIα-expressing neurons in dorsal, but not ventral, subiculum and hippocampal CA1.

Authors:  Christina L Lebonville; Jacqueline E Paniccia; Shveta V Parekh; Lynde M Wangler; Meghan E Jones; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2020-07-24       Impact factor: 7.217

2.  Ovarian steroids modulate leu-enkephalin levels and target leu-enkephalinergic profiles in the female hippocampal mossy fiber pathway.

Authors:  Annelyn Torres-Reveron; Sana Khalid; Tanya J Williams; Elizabeth M Waters; Carrie T Drake; Bruce S McEwen; Teresa A Milner
Journal:  Brain Res       Date:  2008-07-26       Impact factor: 3.252

3.  Opioid inhibition of hippocampal interneurons via modulation of potassium and hyperpolarization-activated cation (Ih) currents.

Authors:  K R Svoboda; C R Lupica
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

4.  Actions of endogenous opioids on NMDA receptor-independent long-term potentiation in area CA3 of the hippocampus.

Authors:  S H Williams; D Johnston
Journal:  J Neurosci       Date:  1996-06-01       Impact factor: 6.167

5.  Phosphorylation of GluR1, ERK, and CREB during spontaneous withdrawal from chronic heroin self-administration.

Authors:  Scott Edwards; Danielle L Graham; Kimberly N Whisler; David W Self
Journal:  Synapse       Date:  2009-03       Impact factor: 2.562

6.  Layer selective presynaptic modulation of excitatory inputs to hippocampal cornu Ammon 1 by mu-opioid receptor activation.

Authors:  A R McQuiston
Journal:  Neuroscience       Date:  2007-10-11       Impact factor: 3.590

7.  Neurobiological Correlates of Pain Avoidance-Like Behavior in Morphine-Dependent and Non-Dependent Rats.

Authors:  Amanda R Pahng; Rod I Paulsen; M Adrienne McGinn; Kimberly N Edwards; Scott Edwards
Journal:  Neuroscience       Date:  2017-10-09       Impact factor: 3.590

8.  The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats.

Authors:  I Nylander; M Vlaskovska; L Terenius
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

9.  Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze.

Authors:  T H Privette; D M Terrian
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

10.  Local hippocampal methamphetamine-induced reinforcement.

Authors:  Ulises M Ricoy; Joe L Martinez
Journal:  Front Behav Neurosci       Date:  2009-11-16       Impact factor: 3.558

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.